Cetera Investment Advisers boosted its holdings in shares of Reinsurance Group of America, Incorporated (NYSE:RGA - Free Report) by 17.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 24,795 shares of the insurance provider's stock after acquiring an additional 3,721 shares during the quarter. Cetera Investment Advisers' holdings in Reinsurance Group of America were worth $5,297,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the business. Spire Wealth Management boosted its position in Reinsurance Group of America by 39.0% during the 4th quarter. Spire Wealth Management now owns 203 shares of the insurance provider's stock worth $43,000 after acquiring an additional 57 shares during the period. Keybank National Association OH boosted its position in Reinsurance Group of America by 2.6% during the 4th quarter. Keybank National Association OH now owns 2,342 shares of the insurance provider's stock worth $500,000 after acquiring an additional 59 shares during the period. Inspire Investing LLC boosted its position in Reinsurance Group of America by 0.5% during the 4th quarter. Inspire Investing LLC now owns 14,224 shares of the insurance provider's stock worth $3,039,000 after acquiring an additional 72 shares during the period. Integrated Investment Consultants LLC boosted its position in Reinsurance Group of America by 2.4% during the 4th quarter. Integrated Investment Consultants LLC now owns 3,349 shares of the insurance provider's stock worth $715,000 after acquiring an additional 77 shares during the period. Finally, UMB Bank n.a. boosted its position in Reinsurance Group of America by 4.9% during the 4th quarter. UMB Bank n.a. now owns 1,745 shares of the insurance provider's stock worth $373,000 after acquiring an additional 81 shares during the period. 95.11% of the stock is currently owned by institutional investors and hedge funds.
Reinsurance Group of America Stock Performance
RGA traded up $0.47 on Monday, hitting $209.59. The company had a trading volume of 421,352 shares, compared to its average volume of 407,959. The company's fifty day moving average price is $191.16 and its 200 day moving average price is $206.70. Reinsurance Group of America, Incorporated has a 1-year low of $159.25 and a 1-year high of $233.81. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.15 and a quick ratio of 0.17. The stock has a market cap of $13.85 billion, a price-to-earnings ratio of 19.51 and a beta of 0.57.
Reinsurance Group of America (NYSE:RGA - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The insurance provider reported $5.66 EPS for the quarter, topping the consensus estimate of $5.33 by $0.33. The company had revenue of $5.26 billion for the quarter, compared to the consensus estimate of $5.74 billion. Reinsurance Group of America had a return on equity of 14.55% and a net margin of 3.24%. The company's revenue for the quarter was down 17.0% on a year-over-year basis. During the same period in the previous year, the business posted $6.02 EPS. Equities analysts predict that Reinsurance Group of America, Incorporated will post 22.9 earnings per share for the current fiscal year.
Reinsurance Group of America Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be given a $0.89 dividend. This represents a $3.56 annualized dividend and a yield of 1.70%. The ex-dividend date of this dividend is Tuesday, May 13th. Reinsurance Group of America's dividend payout ratio is currently 30.04%.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on RGA shares. Piper Sandler reduced their price target on Reinsurance Group of America from $252.00 to $242.00 and set an "overweight" rating for the company in a report on Monday, February 10th. JPMorgan Chase & Co. upgraded Reinsurance Group of America from a "neutral" rating to an "overweight" rating and lifted their price target for the company from $232.00 to $237.00 in a report on Wednesday, April 2nd. UBS Group reiterated a "neutral" rating and set a $216.00 price target (down from $250.00) on shares of Reinsurance Group of America in a report on Wednesday, April 2nd. Keefe, Bruyette & Woods lifted their price target on Reinsurance Group of America from $250.00 to $255.00 and gave the company an "outperform" rating in a report on Wednesday, May 7th. Finally, Wells Fargo & Company lifted their price target on Reinsurance Group of America from $246.00 to $248.00 and gave the company an "overweight" rating in a report on Tuesday, May 6th. Three analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $228.85.
View Our Latest Report on Reinsurance Group of America
Reinsurance Group of America Profile
(
Free Report)
Reinsurance Group of America, Incorporated engages in reinsurance business. The company offers individual and group life and health insurance products, such as term life, credit life, universal life, whole life, group life and health, joint and last survivor insurance, critical illness, disability, and longevity products; asset-intensive and financial reinsurance products; and other capital motivated solutions.
Featured Articles

Before you consider Reinsurance Group of America, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reinsurance Group of America wasn't on the list.
While Reinsurance Group of America currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.